US2013012466A1PendingUtilityA1
Colchicine neoglycosides and methods for their synthesis and use
Est. expiryOct 6, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 35/00A61P 3/00C07H 5/06C07H 15/248A61P 17/00A61P 19/06A61K 45/06A61P 1/00A61K 31/7028
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Colchicine neoglycosides, method for their synthesis and methods for their use are disclosed. The invention provides analogs of colchicine glycosylated to include a sugar moiety on a colchicine scaffold that is generally unglycosylated in nature. The colchicine neoglycosides disclosed herein are shown to have cytotoxic effects equivalent to at least the known cytotoxins paclitaxel and doxorubicin. Further, the neoglycosides disclosed according to the invention have physiologic effects not previously recognized in the alkaloid family that includes colchicine but recognized in other cytotoxic drug families such as the taxanes which act by stabilizing tubulin formation.
Claims
exact text as granted — not AI-modified1 . A colchicine neoglycoside having the structure:
2 . The colchicine neoglycoside of claim 1 , wherein R is:
3 . A methoxyamine-appended colchicine according to the structure:
4 . A method of synthesizing a colchicine neoglycoside according to the reaction:
5 . The method of claim 4 , wherein the reaction is carried out at 40° C. in the presence of 3:1 dimethylformamide/acetic acid.
6 . The method of claim 4 , wherein an intermediate in the synthesis is a methoxyamine-appended colchicine according to the structure:
7 . A method of treating cancer, arthritis, Mediterranean fever, amyloidosis, scleroderma, irritable bowel syndrome or gout comprising administering to a patient in need thereof a therapeutically effective amount of the colchicine neoglycoside according to claim 1 .
8 . The method of claim 7 wherein the colchicine neoglycoside is administered in combination with other therapeutically effective drugs.
9 . The method of claim 7 , wherein the other therapeutically effective drugs are selected from the group consisting of an alkaloid, an anthraclycline, a taxane and combinations thereof.
10 . The method of claim 7 , wherein the colchicine neoglycoside has the structure:
11 . The method of claim 9 , wherein the alkaloid is colchicine.
12 . The method of claim 9 , wherein the anthracycline is doxorubicin.
13 . The method of claim 9 , wherein the taxane is paclitaxel.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.